STAB Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 18:24):

Stats
Dzisiejszy wolumen	5 285.00
Średni wolumen	26 498.00
Kapitalizacja rynkowa	49 991.00
EPS	$0 ( 2024-03-11 )
Następna data zysków	( $0 ) 2024-05-17
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2022-02-22	Chandrasekhar Satishchandran	Buy	0
2021-09-09	Saluck Randy S.	Buy	60 000	Common Stock, par value $0.005 per share
2021-09-09	Barbarick Steve K	Buy	60 000	Common Stock, par value $0.005 per share
2021-09-09	Verny Lea	Buy	60 000	Common Stock, par value $0.005 per share
2021-09-28	Markvicka Taunia	Buy	100 000	Common Stock, par value $0.005 per share

INSIDER POWER
0.00
Last 70 transactions
Buy: 2 421 695 \| Sell: 3 004 967

Statera Biopharma, Inc. Korelacja

10 Najbardziej pozytywne korelacje
NAKD	0.946
BHTG	0.935
TUEM	0.935
LGMK	0.932
MTEX	0.93
GRIN	0.923
AMGN	0.918
PIII	0.917
SMIT	0.917
CREG	0.916

10 Najbardziej negatywne korelacje
ALGM	-0.974
ATRS	-0.966
QIPT	-0.965
FRSG	-0.965
XPDB	-0.963
ITAQ	-0.963
CRUS	-0.963
VPCB	-0.962
NPAB	-0.961
ACQR	-0.961

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Statera Biopharma, Inc. Finanse

Annual	2021
Przychody:	$1.49M
Zysk brutto:	$998 722 (67.16 %)
EPS:	$-2.90

FY	2021
Przychody:	$1.49M
Zysk brutto:	$998 722 (67.16 %)
EPS:	$-2.90

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.471

FY	2019
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.126

Financial Reports:

No articles found.

Statera Biopharma, Inc.

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.